D. A. S. Compston - Concepedia

Author

D. A. S. Compston

Also Known As

Anat Achiron, Compston, DAS, D A Compston, D A S COMPSTON, D A S Compston, D Alastair Compston, D Alastair S Compston, D COMPSTON, D Compston, D. A. COMPSTON

216

Publications

18.9K

Citations

H-Index

189

Concepts

All Affiliations

University of Cambridge Addenbrooke's Hospital University of Wales University College London MRC Biostatistics Unit

About

D. A. S. Compston is an author at University of Cambridge specializing in medicine, multiple sclerosis, and neuroimmunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	45	83	9.4K
2	Public Health	20	22	2.1K
3	Health Sciences	7	7	760
4	Social Sciences	6	6	572
5	Engineering	1	1	42

D. A. S. Compston

134

Publications

16.6K

Citations

H-Index

Page 1

	Year	Citations
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial Jeffrey Cohen, Alasdair Coles, Douglas L. Arnold, The Lancet RheumatologyRelapsing-remitting Multiple SclerosisImmunologyClinical TrialsTreatment Option	2012	1.2K
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial Alasdair Coles, Cary Twyman, Douglas L. Arnold, The Lancet ImmunologyClinical TrialsNeurological ProgressDisease-modifying TherapyMultiple Sclerosis	2012	1.2K
Multiple Sclerosis Severity Score Richard Roxburgh, Shaun R. Seaman, Thomas Masterman, Neurology	2005	945
A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. Susan Huson, D. A. S. Compston, Peggy Clark, Journal of Medical Genetics Mendelian DisorderGenetic DisorderMedicineGeneticsParental Transmission	1989	542
The window of therapeutic opportunity in multiple sclerosis Alasdair Coles, Amanda Cox, Emmanuelle Le Page, Journal of Neurology Neurological DisorderMedicineRehabilitationNeurologyMultiple Sclerosis	2005	501
CLINICAL, PATHOLOGICAL, HLA ANTIGEN AND IMMUNOLOGICAL EVIDENCE FOR DISEASE HETEROGENEITY IN MYASTHENIA GRAVIS D. A. S. Compston, Angela Vincent, John Newsom–Davis, Brain HistocompatibilityImmunohematologySystemic DiseasesNeurological DisorderImmunodeficiencies	1980	467
OCCURRENCE OF A MULTIPLE SCLEROSIS-LIKE ILLNESS IN WOMEN WHO HAVE A LEBER'S HEREDITARY OPTIC NEUROPATHY MITOCHONDRIAL DNA MUTATION A E Harding, Mary G. Sweeney, David H. Miller, Brain	1992	382
A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. N M Milligan, R. Newcombe, D. A. S. Compston Journal of Neurology Neurosurgery & Psychiatry Neurological DisorderMedicineClinical NeurologyClinical TrialsNeurological Progress	1987	364
The British Isles survey of multiple sclerosis in twins C J Mumford, Nicholas Wood, H. Kellar-Wood, Neurology	1994	312
Correlations between changes in disability and T <sub>2</sub> ‐weighted brain MRI activity in multiple sclerosis Massimo Filippi, D. W. Paty, Ludwig Kappos, Neurology	1995	298

Page 1